Charles Schwab’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-119,549
| Closed | -$411K | – | 3626 |
|
|
2024
Q1 | $411K | Hold |
119,549
| – | – | ﹤0.01% | 3095 |
|
|
2023
Q4 | $294K | Hold |
119,549
| – | – | ﹤0.01% | 3223 |
|
|
2023
Q3 | $203K | Hold |
119,549
| – | – | ﹤0.01% | 3285 |
|
|
2023
Q2 | $359K | Buy |
119,549
+101,115
| +549% | +$303K | ﹤0.01% | 3188 |
|
|
2023
Q1 | $49.4K | Hold |
18,434
| – | – | ﹤0.01% | 3347 |
|
|
2022
Q4 | $152K | Buy |
18,434
+5,407
| +42% | +$44.6K | ﹤0.01% | 3223 |
|
|
2022
Q3 | $101K | Sell |
13,027
-76,401
| -85% | -$592K | ﹤0.01% | 3222 |
|
|
2022
Q2 | $255K | Sell |
89,428
-16,619
| -16% | -$47.4K | ﹤0.01% | 3211 |
|
|
2022
Q1 | $531K | Sell |
106,047
-12,507
| -11% | -$62.6K | ﹤0.01% | 3082 |
|
|
2021
Q4 | $2.33M | Buy |
118,554
+7,718
| +7% | +$152K | ﹤0.01% | 2650 |
|
|
2021
Q3 | $3.26M | Buy |
110,836
+31,816
| +40% | +$937K | ﹤0.01% | 2572 |
|
|
2021
Q2 | $3.35M | Buy |
79,020
+2,732
| +4% | +$116K | ﹤0.01% | 2547 |
|
|
2021
Q1 | $3.88M | Buy |
+76,288
| New | +$3.88M | ﹤0.01% | 2413 |
|